Gynecological and obstetrical manifestations of inherited bleeding disorders in women

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 1 S, 2011, Pages 236-245

  Peyvandi, F ^a   Garagiola, I ^a   Menegatti, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Haemophilia; Management; Platelet disorders; Rare bleeding disorders; Von Willebrand disease; Women

Indexed keywords

AMINOCAPROIC ACID; ARGIPRESSIN[1 DEAMINO]; CONTRACEPTIVE AGENT; DESMOPRESSIN; GESTAGEN; GONADORELIN DERIVATIVE; LEVONORGESTREL; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ANEMIA; BLEEDING DISORDER; CHILDBIRTH; CLINICAL FEATURE; CURETTAGE; DAILY LIFE ACTIVITY; DELIVERY; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED HEADACHE; ENDOMETRIUM ABLATION; EVIDENCE BASED PRACTICE; FLUSHING; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC DISEASE; HUMAN; HYPERTENSION; HYPOTENSION; HYSTERECTOMY; MENORRHAGIA; MENSTRUATION; OBSTETRICS; PATHOPHYSIOLOGY; POSTPARTUM HEMORRHAGE; PREGNANCY; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; REPRODUCTIVE HEALTH; REVIEW; SIDE EFFECT; SPONTANEOUS ABORTION; THROMBOCYTE DISORDER; VON WILLEBRAND DISEASE;

BLOOD COAGULATION DISORDERS; DELIVERY, OBSTETRIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC COUNSELING; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL DIAGNOSIS; UTERINE HEMORRHAGE;

EID: 79960624473     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04372.x     Document Type: Review

References (87)

1. Kouides PA. Bleeding symptom assessment and hemostasis evaluation of menorrhagia. Curr Opin Hematol 2008; 15: 465-72.
2. Shaw JA, Shaw HA. Menorrhagia. Medscape, 2011 .12 May 2011.
3. Warner P, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray G. Referral for menstrual problems: cross sectional survey of symptoms, reasons for referral, and management. Br Med J 2001; 323: 24-8.
4. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol 2004; 190: 1216-23.
5. Hagenfeldt K. The role of prostaglandins and allied substances in uterine haemostasis. Contraception 1987; 36: 23-35.
6. Rees MCP, Anderson ABM, Demers LM, Turnbull AC. Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea. Br J Obstet Gynaecol 1984; 91: 673-80.
7. Rees MCP, Anderson ABM, Demers LM, Turnbull AC. Endometrial and myometrial prostaglandin release during menstrual cycle in relation to menstrual blood loss. J Clin Endocrinol Metab 1984; 58: 813-8.
8. Makarainen L, Ylikorkala O. Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen. Br J Obstet Gynaecol 1986; 93: 974-8.
9. Adelantado JM, Rees MCP, Lopez-Bernal A, Turnbull AC. Increased uterine prostaglandin E receptors in menorrhagic women. Br J Obstet Gynaecol 1988; 95: 162-5.
10. Jabbour HN, Sales KJ. Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab 2004; 15: 398-404.
11. Kooy J, Taylor NH, Healy DL, Rogers PA. Endothelial cell proliferation in the endometium of women with menorrhagia and in women following endometrial ablation. Hum Reprod 1996; 11: 1067-72.
12. Gleeson N, Devitt M, Sheppard BL, Bonnar J. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding. Br J Obstet Gynaecol 1993; 100: 768-71.
13. Christiaens GC, Sixma JJ, Haspels AA. Morphology of haemostasis in menstrual endometrium. Br J Obstet Gynaecol 1980; 87: 425-39.
14. Perroneau R. Disputatio medica, inauguralis, de menstruorum profluvio immodico. Edinburgh: Balfour & Smiellie, 1775.
15. McKay WJS. The History of Ancient Gynaecology. London: Bailliere, Tindall & Cox, 1901:302.
16. Diaz A, Laufer MR, Breech LL; American Academy of Pediatrics Committee on Adolescence, American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics 2006; 118: 2245-50.
17. ACOG Committee on Practice Bulletins: Gynecology, American College of Obstetricians and Gynecologists. ACOG practice bulletin: management of anovulatory bleeding. Int J Gynaecol Obstet 2001; 72: 263-71.
18. James AH, Kouides PA, Abdul-Kadir R, Edlund M, Federici AB, Halimeh S, Kamphuisen PW, Konkle BA, Martínez-Perez O, McLintock C, Peyvandi F, Winikoff R. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol 2009; 201: 12.e1-8.
19. Tosetto A, Castaman G, Rodeghiero F. Assessing bleeding in von Willebrand disease with bleeding score. Blood Rev 2007; 21: 89-97.
20. Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D; ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8: 2063-5.
21. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-9.
22. Philipp CS, Faiz A, Dowling NF, Beckman M, Owens S, Ayers C, Bachmann G. Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation. Am J Obstet Gynecol 2008; 198:163.e1-8.
23. Philipp CS, Dilley A, Miller CH, Evatt B, Baranwal A, Schwartz R, Bachmann G, Saidi P. Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost 2003; 1: 477-84.
24. Kadir RA, Edlund M, von Mackensen S. The impact of menstrual disorders on quality of life in women with inherited bleeding disorders. Haemophilia 2010; 16: 832-9.
25. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999; 5: 40-8.
26. Ragni MV, Bontempo FA, Hasset AC. von Willebrand disease and bleeding in women. Hemophilia 1995; 5: 313-7.
27. Kouides PA, Phatak PD, Burkart P, Braggins C, Cox C, Bernstein Z, Belling L, Holmberg P, MacLaughlin W, Howard F. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia 2000; 6: 643-8.
28. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98: 909-18.
29. Federici AB. Clinical diagnosis of von Willebrand's disease. Haemophilia 2004; 10(Suppl. 4): 169-76.
30. Lopez JA, Andrews RK, fshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood 1998; 91: 4397-418.
31. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990; 75: 1383-95.
32. Toogeh G, Sharifian R, Lak M, Safaee R, Artoni A, Peyvandi F. Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran. Am J Hematol 2004; 77: 198-9.
33. Kadir RA, Economides DL, Lee CA. Factor XI deficiency in women. Am J Hematol 1999; 60: 48-54.
34. Lak M, Peyvandi F, Ali Sharifian A, Karimi K, Mannucci PM. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 2003; 1: 1852-3.
35. James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 2005; 11: 295-307.
36. Kirtava A, Drews C, Lally C, Dilley A, Evatt B. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia 2003; 9: 292-7.
37. Kulkarni AA, Lee CA, Kadir RA. Pregnancy in women with congenital factor VII. Haemophilia 2006; 12: 413-6.
38. Siboni SM, Spreafico M, Calò L, Maino A, Santagostino E, Federici AB, Peyvandi F. Gynaecological and obstetrical problems in women with different bleeding disorders. Haemophilia 2009; 15: 1291-9.
39. Silwer J. von Willebrand's disease in Sweden. Acta Paediatr Scand 1973; 238: 1-159.
40. Kouides PA. Females with von Willebrand disease: 72 years as the silent majority. Haemophilia 1998; 4: 665-76.
41. Skankar M, Chi C, Kadir RA. Review of quality of life: menorrhagia in women with or without inherited bleeding disorders. Haemophilia 2008; 14: 15-20.
42. Kadir RA, James AH. Reproductive health in women with bleeding disorders. World Federation of Hemophilia (WFH), 2009; .
43. Lee CA. Hemophilia A and hemophilia B, in Inherited bleeding disorders in women (eds. Lee CA, Kadir RA, Koudies PA) Oxford: Wiley-Blackwell, 2009.
44. James AH. Women and bleeding disorders. Haemophilia 2010; 16(Suppl. 5): 160-7.
45. Philipp C. Platelet Disorders in Inherited Bleeding Disorders in Women (eds. Lee CA, Kadir RA, Koudies PA, eds). Oxford, UK: Wiley-Blackwell, 2009.
46. Nurden AT. Glanzmann thrombasthenia. Orphanet J Rare Dis 2006; 1: 10.
47. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2000; 4: CD000249.
48. Berntorp E, Follrud C, Lethagen S. No increased risk of venous thrombosis in women taking tranexamic acid. Thromb Haemost 2001; 86: 714-5.
49. Sundström A, Seaman H, Kieler H, Alfredsson L. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database. BJOG 2009; 116: 91-7.
50. Ip PPC, Lam KW, Cheung CL, Yeung MC, Pun TC, Chan QK, Cheung AN. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas. Am J Surg Pathol 2007; 31: 1215-24.
51. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Culleré M, Ross FP, Coller BS, Teitelbaum S, Hynes RO. β3-integrin-deficient mice are a model for Glanzmann thrombastenia showing placental defects and reduced survaival. J Clin Invest 1999; 103: 229-38.
52. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999; 107: 204-6.
53. Evron S, Anteby SO, Brzezinsky A, Samueloff A, Eldor A. Congenital afibrinogenemia and recurrent early abortion: a case report. Eur J Obstet Gynecol Reprod Biol 1985; 19: 307-11.
54. Kobayashi T, Kanayama N, Tokunaga N, Asahina T, Terao T. Prenatal and peripartum management of congenital afibrinogenaemia. Br J Haematol 2000; 109: 364-6.
55. Burrows RF, Ray JG, Burrows EA. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. Obstet Gynecol Surv 2000; 55: 103-8.
56. Asahina T, Kobayashi T, Okada Y, Itoh M, Yamashita M, Inamato Y, Terao T. Studies on the role of adhesive proteins in maintaining pregnancy. Horm Res 1998; 50(Suppl 2): 37-45.
57. Wartiovaara J, Leivo I, Virtanen I, Vaheri A, Graham CF. Cell surface and extracellular matrix glycoprotein fibronectin. Expression in embryogenesis and in teratocarcinoma differentiation. Ann NY Acad Sci 1978; 312: 132-41.
58. Iwaki T, Sandoval-Cooper MJ, Paiva M, Kobayashi T, Ploplis VA, Castellino FJ. Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse. Am J Pathol 2002; 160: 1021-34.
59. Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 176-82.
60. Kriplani A, Singh BM, Sowbernika R, Choudhry VP. Successful pregnancy outcome in Bernard-Soulier syndrome. J Obstet Gynaecol Res 2005; 31: 52-6.
61. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105: 304-21.
62. Khan KS, Wojdyla D, Say L, Gü lmezoglu AM, van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-74.
63. WHO, UNICEF, UNFPA, The World Bank. Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNFPA, and the World Bank. World Health Organization, editor. Geneva: WHO Press, World Health Organization, 2005: 16-7, 23-27, 29-38.
64. Hill K, AbouZhar C, Wardlaw T. Estimates of maternal mortality for 1995. Bull World Health Organ 2001; 79: 182-93.
65. World Health Organization. Managing Complications in Pregnancy and Childbirth: A guide for midwives and doctors. Geneva: Department of Reproductive Health and Research, World Health Organization, 2003.
66. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC III, Hauth JC, Wenstrom KD (editors). Obstetrical hemorrhage. Williams Obstetrics, 21st edn. New York: McGraw-Hill Professional, 2001: 619-70.
67. Marchant S, Alexander J, Garcia J, Ashurst H, Alderdice F, Keene J. A survey of women's experiences of vaginal loss from 24 hours to three months after childbirth (the BLiPP Study). Midwifery 1999; 15: 72-81.
68. Dahlman T, Hellgren M, Blombäck M. Changes in blood coagulation and fibrinolysis in the normal puerperium. Gynecol Obstet Invest 1985; 20: 37-44.
69. Kadir RA, Economides DL, Braithwaite J, Goldman E, Lee CA. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 1997; 104: 803-10.
70. James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost 2007; 5: 1165-9.
71. Sherer DM, Lerner R. Glanzmann's thrombasthenia in pregnancy: a case and review of the literature. Am J Perinatol 1999; 16: 297-301.
72. Goodwin TM. Congenital hypofibrinogenemia in pregnancy. Obstet Gynecol Surv 1989; 44: 157-61.
73. Noia G, De Carolis S, De Stefano V, Ferrazzani S, De Santis L, Carducci B, De Santis M, Caruso A. Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature. Acta Obstet Gynecol Scand 1997; 76: 890-2.
74. Rizk DE, Castella A, Shaheen H, Deb P. Factor VII deficiency detected in pregnancy: a case report. Am J Perinatol 1999; 16: 223-6.
75. Girolami A, Lazzarin M, Scarpa R, Brunetti A. Further studies on the abnormal factor X (factor X Friuli) coagulation disorder: a report of another family. Blood 1971; 37: 534-41.
76. Salomon O, Steinberg DM, Tamarin I, Zivelin A, Seligsohn U. Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagul Fibrinolysis 2005; 16: 37-41.
77. Pacheco LD, Costantine MM, Saade GR, Mucowski S, Hankins GDV, Sciscione AC. von Willebrand disease and pregnancy: a practical approach for the diagnosis and treatment. Am J Obstet Gynecol 2010; 15: 194-200.
78. Mannucci PM. Treatment of von Willebrand's Disease. N Engl J Med 2004; 351: 683-94.
79. Bolton-Maggs PH, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, Collins PW, Kitchen S, Dolan G, Mumford AD. The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004; 10: 593-628.
80. Trehan AK, Fergusson IL. Congenital afibrinogenaemia and successful pregnancy outcome. Br J Obstet Gynaecol 1991; 98: 722-4.
81. Frenkel E, Duksin C, Herman A, Sherman DJ. Congenital hypofibrinogenemia in pregnancy: report of two cases and review of the literature. Obstet Gynecol Surv 2004; 59: 775-9.
82. Dupuy E, Soria C, Molho P, Zini JM, Rosenstingl S, Laurian C, Bruneval P, Tobelem G. Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo. Thromb Res 2001; 102: 211-9.
83. Robertson LE, Wasserstrum N, Banez E, Vasquez M, Sears DA. Hereditary factor VII deficiency in pregnancy: peripartum treatment with factor VII concentrate. Am J Hematol 1992; 40: 38-41.
84. Bofill JA, Young RA, Perry KG Jr. Successful pregnancy in a woman with severe factor X deficiency. Obstet Gynecol 1996; 88: 723.
85. Rodeghiero F, Castaman GC, Di Bona E, Ruggeri M, Dini E. Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case. Blut 1987; 55: 45-8.
86. Asahina T, Kobayashi T, Takeuchi K, Kanayama N. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstet Gynecol Surv 2007; 62: 255-60.
87. Kadir R, Chi C, Bolton-Maggs P. Pregnancy and rare bleeding disorders. Haemophilia 2009; 15: 990-1005.